Drugs / HPC
last change Aug 2016 re-read 2 minutes ago

HPC

Developed for
eosinophilic granulomatosis with polyangiitis
Investigated by
Mounzer Agha

Trials 1 · a red edge is where a trial was stopped

20162017201820192020202120222023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 0 NCT02728271 Apr → Jul 2016 eosinophilic granulomatosis with polyangiitis Mounzer Agha Terminated No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as HPC ClinicalTrials.gov intervention name — accepted as the source's own label NCT02728271